Np mrd loader

Record Information
Version1.0
Created at2021-01-06 01:49:38 UTC
Updated at2021-07-15 17:24:14 UTC
NP-MRD IDNP0016986
Secondary Accession NumbersNone
Natural Product Identification
Common NameOscillacyclamide A
Provided ByNPAtlasNPAtlas Logo
Description Oscillacyclamide A is found in Oscillatoria. It was first documented in 2012 (PMID: 34383397). Based on a literature review very few articles have been published on 2-[(4R,7R,14S,20R,23R,26R,29S,36R,39R,42R,45R,51R)-23-(4-aminobutyl)-20-(carboxymethyl)-2,5,12,15,18,21,24,27,34,37,40,43,46,49-tetradecahydroxy-39-[(C-hydroxycarbonimidoyl)methyl]-36-(hydroxymethyl)-26-[(4-hydroxyphenyl)methyl]-14,45-bis[(1H-indol-3-yl)methyl]-29-methyl-42-[(1S)-1-[(3-methylbut-2-en-1-yl)oxy]ethyl]-4,7-bis(propan-2-yl)-9,31,53-trithia-3,6,13,16,19,22,25,28,35,38,41,44,47,50,55,56,57-heptadecaazatetracyclo[50.2.1.1⁸,¹¹.1³⁰,³³]Heptapentaconta-1(54),2,5,8(57),10,12,15,18,21,24,27,30(56),32,34,37,40,43,46,49,52(55)-icosaen-51-yl]acetic acid (PMID: 28905052) (PMID: 34383398) (PMID: 34383396) (PMID: 34384147) (PMID: 34384146) (PMID: 34384145).
Structure
Thumb
Synonyms
ValueSource
2-[(4R,7R,14S,20R,23R,26R,29S,36R,39R,42R,45R,51R)-23-(4-Aminobutyl)-20-(carboxymethyl)-2,5,12,15,18,21,24,27,34,37,40,43,46,49-tetradecahydroxy-39-[(C-hydroxycarbonimidoyl)methyl]-36-(hydroxymethyl)-26-[(4-hydroxyphenyl)methyl]-14,45-bis[(1H-indol-3-yl)methyl]-29-methyl-42-[(1S)-1-[(3-methylbut-2-en-1-yl)oxy]ethyl]-4,7-bis(propan-2-yl)-9,31,53-trithia-3,6,13,16,19,22,25,28,35,38,41,44,47,50,55,56,57-heptadecaazatetracyclo[50.2.1.1,.1,]heptapentaconta-1(54),2,5,8(57),10,12,15,18,21,24,27,30(56),32,34,37,40,43,46,49,52(55)-icosaen-51-yl]acetateGenerator
Chemical FormulaC87H109N21O22S3
Average Mass1897.1300 Da
Monoisotopic Mass1895.72182 Da
IUPAC Name2-[(4R,7R,14S,20R,23R,26R,29S,36R,39R,42R,45R,51R)-23-(4-aminobutyl)-39-(carbamoylmethyl)-51-(carboxymethyl)-36-(hydroxymethyl)-26-[(4-hydroxyphenyl)methyl]-14,45-bis[(1H-indol-3-yl)methyl]-29-methyl-42-[(1S)-1-[(3-methylbut-2-en-1-yl)oxy]ethyl]-2,5,12,15,18,21,24,27,34,37,40,43,46,49-tetradecaoxo-4,7-bis(propan-2-yl)-9,31,53-trithia-3,6,13,16,19,22,25,28,35,38,41,44,47,50,55,56,57-heptadecaazatetracyclo[50.2.1.1^{8,11}.1^{30,33}]heptapentaconta-1(54),8(57),10,30(56),32,52(55)-hexaen-20-yl]acetic acid
Traditional Name[(4R,7R,14S,20R,23R,26R,29S,36R,39R,42R,45R,51R)-23-(4-aminobutyl)-39-(carbamoylmethyl)-51-(carboxymethyl)-36-(hydroxymethyl)-26-[(4-hydroxyphenyl)methyl]-14,45-bis(1H-indol-3-ylmethyl)-4,7-diisopropyl-29-methyl-42-[(1S)-1-[(3-methylbut-2-en-1-yl)oxy]ethyl]-2,5,12,15,18,21,24,27,34,37,40,43,46,49-tetradecaoxo-9,31,53-trithia-3,6,13,16,19,22,25,28,35,38,41,44,47,50,55,56,57-heptadecaazatetracyclo[50.2.1.1^{8,11}.1^{30,33}]heptapentaconta-1(54),8(57),10,30(56),32,52(55)-hexaen-20-yl]acetic acid
CAS Registry NumberNot Available
SMILES
CC(C)[C@H]1NC(=O)[C@H](NC(=O)C2=CSC(=N2)[C@@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CO)NC(=O)C2=CSC(=N2)[C@H](C)NC(=O)[C@@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)C2=CSC1=N2)[C@H](C)OCC=C(C)C)C(C)C
InChI Identifier
InChI=1S/C87H109N21O22S3/c1-41(2)24-26-130-45(8)72-84(129)101-57(29-48-34-91-53-18-12-10-16-51(48)53)74(119)93-36-67(113)96-60(32-69(116)117)86-104-64(39-132-86)82(127)106-70(42(3)4)83(128)107-71(43(5)6)87-105-63(40-133-87)80(125)99-56(28-47-33-90-52-17-11-9-15-50(47)52)73(118)92-35-66(112)95-59(31-68(114)115)77(122)97-54(19-13-14-25-88)75(120)98-55(27-46-20-22-49(110)23-21-46)76(121)94-44(7)85-103-62(38-131-85)81(126)102-61(37-109)79(124)100-58(30-65(89)111)78(123)108-72/h9-12,15-18,20-24,33-34,38-40,42-45,54-61,70-72,90-91,109-110H,13-14,19,25-32,35-37,88H2,1-8H3,(H2,89,111)(H,92,118)(H,93,119)(H,94,121)(H,95,112)(H,96,113)(H,97,122)(H,98,120)(H,99,125)(H,100,124)(H,101,129)(H,102,126)(H,106,127)(H,107,128)(H,108,123)(H,114,115)(H,116,117)/t44-,45-,54+,55+,56-,57+,58+,59+,60+,61+,70+,71+,72+/m0/s1
InChI KeyDECBPJPIDHVROG-LEKXQQIESA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
OscillatoriaNPAtlas
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP-4.1ChemAxon
pKa (Strongest Acidic)3.29ChemAxon
pKa (Strongest Basic)10.24ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count26ChemAxon
Hydrogen Donor Count22ChemAxon
Polar Surface Area671.05 ŲChemAxon
Rotatable Bond Count23ChemAxon
Refractivity477.64 m³·mol⁻¹ChemAxon
Polarizability196.41 ųChemAxon
Number of Rings9ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
NPAtlas IDNPA027375
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound146683709
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Alexandru-Crivac CN, Umeobika C, Leikoski N, Jokela J, Rickaby KA, Grilo AM, Sjo P, Plowright AT, Idress M, Siebs E, Nneoyi-Egbe A, Wahlsten M, Sivonen K, Jaspars M, Trembleau L, Fewer DP, Houssen WE: Cyclic peptide production using a macrocyclase with enhanced substrate promiscuity and relaxed recognition determinants. Chem Commun (Camb). 2017 Sep 26;53(77):10656-10659. doi: 10.1039/c7cc05913b. [PubMed:28905052 ]
  2. Mitchell PM: The cost-effectiveness of what in health and care?. 2021 Feb. [PubMed:34383398 ]
  3. Authors unspecified: Ozanimod. 2012. [PubMed:34383397 ]
  4. Authors unspecified: Ponesimod. 2012. [PubMed:34383396 ]
  5. Lee J, Cho Y, Choi KH, Hwang I, Oh YL: Metastatic leiomyosarcoma of the thyroid gland: cytologic findings and differential diagnosis. J Pathol Transl Med. 2021 Aug 13. pii: jptm.2021.06.23. doi: 10.4132/jptm.2021.06.23. [PubMed:34384147 ]
  6. Rossouw HM, Nagel SE, Pillay TS: Comparability of 11 different equations for estimating LDL cholesterol on different analysers. Clin Chem Lab Med. 2021 Aug 11. pii: cclm-2021-0747. doi: 10.1515/cclm-2021-0747. [PubMed:34384146 ]
  7. Winkel P, Hilden J, Jakobsen JC, Lindschou J, Jensen GB, Kjoller E, Sajadieh A, Kastrup J, Kolmos HJ, Larsson A, Arnlov J, Bjerre M, Gluud C: A screening method to spot biomarkers that may warn of serious events in a chronic disease - illustrated by cardiological CLARICOR trial data. Clin Chem Lab Med. 2021 Aug 12. pii: cclm-2021-0333. doi: 10.1515/cclm-2021-0333. [PubMed:34384145 ]
  8. Lombardi Y, Hiesse C, Ridel C, Touzot M: From combined heart-kidney to kidney transplantation program: what nephrologists should know about dilated cardiomyopathy. Transpl Int. 2021 Aug;34(8):1573-1575. doi: 10.1111/tri.13948. [PubMed:34384144 ]
  9. Kennedy LJ, Cukier S, Khoury L, Steeves D: 'You drink at home so they can go to work safely': A case study exploring alcohol marketing during the COVID-19 pandemic. Drug Alcohol Rev. 2021 Aug 12. doi: 10.1111/dar.13374. [PubMed:34384143 ]